Skip to main content

Table 2 Infection characteristics of 75 patient with enterococcal PJI

From: Enterococcal periprosthetic joint infection: clinical and microbiological findings from an 8-year retrospective cohort study

Variable

All episodes

(n = 75)

Monomicrobial

(n = 37)

Polymicrobial

(n = 38)

P value

Infection manifestation according to the time after last surgery

 Early

27 (36)

10 (27)

17 (45)

0.150

 Delayed

30 (40)

17 (46)

13 (34)

0.351

 Late

18 (24)

10 (27)

8 (21)

0.597

Median delay from last revision to PJI (range) - months

8.7 (0.5–336)

10.2 (0.3–336)

5.0 (0.4–133)

0.588

Median delay from primary implantation of prosthesis to PJI (range) - months

47.7 (0.3–418)

36.4 (0.3–418)

56.6 (0.4–373)

0.810

Presumed route of infection

 Perioperativea

61 (81)

25 (68)

36 (95)

0.003

 Hematogenous

13 (17)

12 (32)

1 (3)

< 0.001

 Direct extension by adjacent infectious focus (contiguous)

1 (1)

1 (3)

 

Signs and symptoms

 Joint pain

48/70 (69)

22/32 (69)

26/38 (68)

1.000

 Local signs

46 (61)

20 (54)

26 (68)

0.241

 Sinus tract

16 (21)

3 (8)

13 (34)

0.010

 Prosthesis loosening in x-ray

16 (21)

5 (14)

11 (29)

0.158

Laboratory results at admission

 Serum C-reactive protein

  Median (range) - mg/l

36 (1–295)

45 (12–229)

36 (1–295)

0.936

  Increased (> 10 mg/l)

63 (84)

30 (81)

33 (87)

0.544

 White blood cell count

  Median (range) – G/l

7.9 (3.2–34.23)

7.4 (4.8–22.4)

8.3 (3.2–34.3)

0.992

  Increased (> 10 G/l)

18 (24)

8 (22)

10 (26)

0.788

Synovial fluid leukocyte count

 Increased valueb

25/29 (86)

16/17 (94)

9/12 (75)

0.279

 Median absolute count (range) - 103/μl

20.3 (0.42–160)

23 (1.8–160)

7.1 (0.4–140)

0.097

Histopathology consistent with infection

53/61 (87)

26/28 (93)

27/33 (82)

0.294

  1. Data are no. (%) of patients, unless otherwise indicated. Where the denominator is shown, data was not available for all patients
  2. aAmong them 13 cases (9 polymicrobial and 4 monomicrobial) occurred during surgical and antimicrobial treatment of a PJI caused by another pathogen
  3. bIncreased absolute number of leukocytes or percentage of granulocytes